Cargando…
Epigenetic Suppression of the IL-7 Pathway in Progressive Glioblastoma
Background: Immune evasion in glioblastoma (GBM) shields cancer cells from cytotoxic immune response. Methods: We investigated CpG methylation in promoters, genes, and pathways in 22 pairs of formalin-fixed paraffin-embedded sequential (FFPE) GBM using restricted resolution bisulfite sequencing (RRB...
Autores principales: | Tompa, Marton, Kraboth, Zoltan, Galik, Bence, Kajtar, Bela, Gyenesei, Attila, Kalman, Bernadette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496096/ https://www.ncbi.nlm.nih.gov/pubmed/36140275 http://dx.doi.org/10.3390/biomedicines10092174 |
Ejemplares similares
-
DNA CpG methylation in sequential glioblastoma specimens
por: Kraboth, Zoltan, et al.
Publicado: (2020) -
Involvement of the Catecholamine Pathway in Glioblastoma Development
por: Kraboth, Zoltán, et al.
Publicado: (2021) -
Longitudinal Characteristics of Glioblastoma in Genome-Wide Studies
por: Kraboth, Zoltan, et al.
Publicado: (2019) -
ß-Adrenoreceptors in Human Cancers
por: Kraboth, Zoltan, et al.
Publicado: (2023) -
Clinicopathological analysis of diffuse large B-cell lymphoma using molecular biomarkers: a retrospective analysis from 7 Hungarian centers
por: Balikó, Anett, et al.
Publicado: (2023)